WallStreetZenWallStreetZen

NASDAQ: ANL
Adlai Nortye Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ANL stock forecasts and price targets.

Forecast return on equity

Is ANL forecast to generate an efficient return?

Company
188.65%
Industry
74.59%
Market
337.82%
ANL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ANL forecast to generate an efficient return on assets?

Company
67.46%
Industry
23.33%
ANL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ANL earnings per share forecast

What is ANL's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.36
Avg 2 year Forecast
-$0.36
Avg 3 year Forecast
$0.43

ANL revenue forecast

What is ANL's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$173.6M

ANL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANL$1.28N/AN/A
CELU$1.67$6.00+259.28%Buy
GRCE$3.36N/AN/A
KZR$6.30$6.00-4.76%Hold
BCAB$0.78N/AN/A
View Top Biotech Stocks

Adlai Nortye Stock Forecast FAQ

What is ANL's earnings growth forecast for 2025-2027?

(NASDAQ: ANL) Adlai Nortye's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 72.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 103.38%.

Adlai Nortye's earnings in 2025 is -$51,869,000.On average, 2 Wall Street analysts forecast ANL's earnings for 2025 to be -$40,250,812, with the lowest ANL earnings forecast at -$39,055,243, and the highest ANL earnings forecast at -$41,844,904. On average, 2 Wall Street analysts forecast ANL's earnings for 2026 to be -$40,250,812, with the lowest ANL earnings forecast at -$39,055,243, and the highest ANL earnings forecast at -$41,844,904.

In 2027, ANL is forecast to generate $48,077,359 in earnings, with the lowest earnings forecast at $46,649,318 and the highest earnings forecast at $49,981,413.

If you're new to stock investing, here's how to buy Adlai Nortye stock.

What is ANL's revenue growth forecast for 2025-2027?

(NASDAQ: ANL) Adlai Nortye's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 284.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.53%.

Adlai Nortye's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast ANL's revenue for 2025 to be $0, with the lowest ANL revenue forecast at $0, and the highest ANL revenue forecast at $0. On average, 2 Wall Street analysts forecast ANL's revenue for 2026 to be $0, with the lowest ANL revenue forecast at $0, and the highest ANL revenue forecast at $0.

In 2027, ANL is forecast to generate $19,219,873,417 in revenue, with the lowest revenue forecast at $18,648,657,273 and the highest revenue forecast at $19,981,494,942.

What is ANL's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ANL) forecast ROA is 67.46%, which is higher than the forecast US Biotechnology industry average of 23.33%.

What is ANL's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ANL) Adlai Nortye's current Earnings Per Share (EPS) is -$1.62. On average, analysts forecast that ANL's EPS will be -$0.36 for 2025, with the lowest EPS forecast at -$0.35, and the highest EPS forecast at -$0.38. On average, analysts forecast that ANL's EPS will be -$0.36 for 2026, with the lowest EPS forecast at -$0.35, and the highest EPS forecast at -$0.38. In 2027, ANL's EPS is forecast to hit $0.43 (min: $0.42, max: $0.45).

What is ANL's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ANL) forecast ROE is 188.65%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.